Goldspan Health review
Two things shape this listing more than the sticker does. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product instead links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each paired with B12. That storefront then advertises the price as monthly while stating that a new supply arrives automatically every four weeks, which means thirteen charges a year rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 more than a monthly reading implies. Both figures were already at the higher end of the compounded market before that adjustment. The credit side is real enough: a longevity platform spanning eleven protocol categories, medication dispensed through licensed 503A and 503B pharmacies, and a flat price at any dose. The fifty-state claim on the homepage is qualified by the terms, which say some therapies are unavailable in some states.
- Six-factor Editors' Rating
- Source-based review
This review draws on the provider’s public pricing, terms and disclosures. No one on this desk is your clinician.
Goldspan Health at a glance
- Semaglutide
- $229 per 4 weeks
- Tirzepatide
- $299 per 4 weeks
- Coverage
- All 50 states claimed, with exceptions in the terms
- Brand-name
- Compounded only
How we scored Goldspan Health
Each score comes out of Goldspan Health's published pricing, disclosures and oversight, and the six combine into the 32/100 Editors' Rating on our weighted six-factor framework. A commission never changes a provider's score.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the best we track — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Primary source
- The company's own site
Prices checked in October 2026. Two things reshape the price before you get to it. Goldspan publishes no figure anywhere on its own website — you have to follow a product link out to a separate storefront to learn that semaglutide is $229 and tirzepatide $299. And that storefront bills every four weeks while calling it monthly, so a year is thirteen charges: about $2,977 and $3,887, roughly $230 and $300 more than twelve payments would suggest. Both were already among the pricier compounded options here. Medication is dispensed through licensed 503A and 503B pharmacies, and the fifty-state claim on the homepage is qualified by the terms.
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $229 | Injection with B12, any doseAdvertised as monthly but shipped and charged every 4 weeks — thirteen charges a year, about $2,977, not the $2,748 twelve payments imply. The figure appears nowhere on Goldspan's own site, only on the separate storefront its product links lead to. |
| Compounded tirzepatide | $299 | Injection with B12, any doseSame 4-week cycle: about $3,887 a year across thirteen charges rather than $3,588. Also priced only on the third-party storefront. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Goldspan Health's public disclosures at last review and change often; confirm the current number on Goldspan Health's own site.
What we like
- A flat price at any dose, so titrating up does not raise the bill
- Medication dispensed through licensed 503A and 503B pharmacies
- Sits inside a broad longevity platform of eleven protocol categories
- Both weight-loss protocols pair the molecule with B12 or glycine, at the same price, rather than selling it bare
- The storefront says you can change or cancel anytime
The caveats
- No price appears anywhere on Goldspan's own site — you must click out to a third-party storefront
- A lab panel is required 60–90 days after you start and once a year after that, at extra cost
- Billed every 4 weeks while advertised as monthly, which is thirteen charges a year
- The real annual cost is about $2,977 and $3,887, not the $2,748 and $3,588 monthly reading
- Among the more expensive compounded GLP-1s here even before the cycle adjustment
- The homepage claims 50 states while the terms carve out exceptions
- Nothing addresses pregnancy, breastfeeding or postpartum timing
Goldspan Health for mothers: our verdict
Goldspan Health costs about $229/4 weeks, more than most providers charge. Where it earns its score is support as your dose changes. Where it loses ground is price transparency.
Goldspan Health pricing
- Compounded semaglutide — Injection with B12, any dose: $229/4 wks
- Compounded tirzepatide — Injection with B12, any dose: $299/4 wks
For comparison, the typical price we see is about $196/month — Goldspan Health sits above it. Over a year at that rate, you'd spend about $2,977. The price is the same at every dose, so the bill doesn't grow as you step up. Each billing cycle is 4 weeks, so a year is 13 payments, not 12.
What's included: the medication.
What Goldspan Health prescribes
Goldspan Health prescribes semaglutide and tirzepatide. Semaglutide is the drug in Wegovy and Ozempic; tirzepatide, the drug in Zepbound and Mounjaro, also acts on GIP and is often preferred where insulin resistance drives weight. Expect compounded medication, not Wegovy or Zepbound pens. That's why the price is lower, and also why the FDA hasn't approved the finished product.
Before you start the intake
Goldspan Health says it serves all 50 states, though availability can vary, so check yours early.
How Goldspan Health compares
Close in price to Goldspan Health, and worth comparing:
- Mixx Health & Wellness — $235/mo, tirzepatide
- Raeliva — $219/mo, semaglutide and tirzepatide, same price at every dose
- Luvo Health — $209/4 wks, semaglutide and tirzepatide, same price at every dose, brand-name pens available
Who Goldspan Health suits, and who should look elsewhere
Worth it if…
- You may want to switch between semaglutide and tirzepatide later on.
Give it a miss if…
- You specifically want an FDA-approved brand pen with its own pregnancy and breastfeeding labeling.
- Budget is tight — it costs more than most of the providers we've reviewed.
- You're breastfeeding or trying to conceive and want a prescriber to weigh in on timing — see CoreAge Rx, a featured partner.
Can you trust it?
It's fair to ask any compounded provider two things: which pharmacy makes the medication, and what's in it. How we score clinical oversight is set out in our methodology.
Weight-loss treatment is not recommended during pregnancy. If you are breastfeeding or planning pregnancy, discuss the exact medicine, formulation and timing with your own clinician; limited milk-transfer data do not establish infant safety.
The bottom line
Goldspan Health costs more than most, so it has to earn the difference — its strongest card is support as your dose changes. If you're still choosing, compare it with CoreAge Rx, a featured partner.
The bottom line for mothers
Best for: A family already buying peptide protocols who wants a GLP-1 on the same platform, and who will do the thirteen-payment arithmetic before comparing it with a monthly seller.
Alternatives to Goldspan Health
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge RxCoreAge RxFeatured partner
The one program on our list whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Enhance MD
One of the better-disclosed cash compounders we've reviewed for mothers — a named medical director, named pharmacies and real Quest lab work behind flat-per-dose pricing. The catch is that the low headline number you'll see quoted is the 12-month prepay rate, not the month-to-month price.
- Visit bmiMD
A complete plan table and genuine nationwide coverage, undercut by a homepage that strikes the same product through from two different “regular” prices.
Providers like Goldspan Health
Keep comparing Goldspan Health
Head-to-head & alternatives
Ranked boards
- The 2026 guide to the best GLP-1 for moms
- Best GLP-1 for women — PCOS & menopause
- Best GLP-1 for first-timers & beginners
- Cheapest GLP-1 without insurance
- Best GLP-1 after baby — postpartum providers ranked
- Best GLP-1 with insurance & coverage help
- Best GLP-1 providers for PCOS
- Best GLP-1 for perimenopause & menopause
- Cheapest tirzepatide online, month to month
- Cheapest semaglutide online, month to month
Goldspan Health, answered
- Why is there no price on the website?
- Because there genuinely is not one. Goldspan's homepage and weight-loss category page carry no dollar figure at all. Every product links out to a separate storefront on another domain, and only there does a price appear — $229 for semaglutide and $299 for tirzepatide, both with B12. Buying from one company through another company's checkout is worth knowing before you start.
- What does billing every four weeks cost me?
- About one extra payment a year. The storefront advertises monthly pricing but states that a new supply arrives automatically every four weeks, which is thirteen shipments a year rather than twelve. Semaglutide works out to roughly $2,977 a year instead of $2,748, and tirzepatide to about $3,887 instead of $3,588 — around $230 and $300 more than a monthly reading suggests.
- Is it available everywhere?
- Not quite, by its own account. The homepage says "In 50 states" and the terms then say some therapies are unavailable in certain states. The claim and the qualification sit in different documents, so check that the specific protocol you want is offered where you live rather than trusting the headline.
Pricing, states and verification reflect Goldspan Health's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.